hepatocellular carcinoma

Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary

Literature (2)

Literature for DOID 684: hepatocellular carcinoma

Xenbase Articles Publications associated with this Disease Ontology entry or its descendants

:
(

Denotes literature images)

Aberrant regulation of Wnt signaling in hepatocellular carcinoma., Liu LJ,Xie SX,Chen YT,Chen YT,Xue JL,Zhang CJ,Zhu F, World J Gastroenterol. September 7, 2016; 22(33):2219-2840.
Sorafenib Activity and Disposition in Liver Cancer Does Not Depend on Organic Cation Transporter 1., Chen M,Neul C,Schaeffeler E,Frisch F,Winter S,Schwab M,Koepsell H,Hu S,Laufer S,Baker SD,Sparreboom A,Nies AT, Clin Pharmacol Ther. January 1, 2020; 107(1):1532-6535.

Aberrant regulation of Wnt signaling in hepatocellular carcinoma., Liu LJ,Xie SX,Chen YT,Chen YT,Xue JL,Zhang CJ,Zhu F, World J Gastroenterol. September 7, 2016; 22(33):2219-2840.

Sorafenib Activity and Disposition in Liver Cancer Does Not Depend on Organic Cation Transporter 1., Chen M,Neul C,Schaeffeler E,Frisch F,Winter S,Schwab M,Koepsell H,Hu S,Laufer S,Baker SD,Sparreboom A,Nies AT, Clin Pharmacol Ther. January 1, 2020; 107(1):1532-6535.